.png "back to home page")
The risk of a clot is roughly one in 100,000 for people in their 40s, but rises to one in 60,000 for people in their 30s. Two in a million people in their 40s died rising to four per million people in their 30s. https://t.co/eoUUHtYxNS
— Tassos (@tg128) May 7, 2021
Oscar (masked dog) Interesting: https://t.co/Os6bTQj3v6
— @CDavidNaylor (@cdavidnaylor) May 7, 2021
Old Fart: Makes sense. AZ effective w/ fine 1st dose durability. VIIT side-effect rare, early (<28d), but also very serious. So the balance tips against AZ 1st dose as cases drop (UK) &/or alternative supplies rise (Canada).
If it's not one thing, it's the next...https://t.co/9iENbGcUN8
— 05.12.2020 (@LadyDre_18) May 7, 2021
血栓問題、メーカー所在の英国でも：40歳以下はアストラゼネカ製以外のワクチンを推奨（Under 40s to be offered alternative to AZ vaccine: BBC)https://t.co/OWGRAmI0g2
— 滝田洋一（日本経済新聞） (@yoichitakita) May 7, 2021
ーー日本では16歳以上の全国民用にアストラゼネカ製以外のワクチン（ファイザー製とモデルナ製）を確保済み。
Just a conspiracy eh...
— Mr Free Speech - Centrefuter (@Centrefuter) May 7, 2021
What's worse is that they're still planning to give the under 40s a second dose of it of they had a first...https://t.co/T7uONSLvc7
UK will offer an alternative to AZ vaccine to those under 40 due to rare blood clot events. https://t.co/S8MRFGjdCI. In India 18+ are rushing to get jabbed with the vaccine without any note of safety precaution by the govt.
— DivyaET (@rdivia) May 7, 2021
Nice of no one to care that I’ve been popping the combined oral contraception for more years of my life than I haven’t with a way higher risk but ok. I hope the remaining AZ stock not needed is shipped ASAP to countries that need it more. https://t.co/pTkc90HgZR
— skr ⚜️ (@lcrzbrg) May 7, 2021
People under the age of 40 in the U.K. are to be offered an alternative to the Oxford-AstraZeneca Covid-19 vaccine, as concerns over links to rare blood clots continue to weigh on its roll out.https://t.co/8WLGvUWSSZ
— Chloe Taylor (@ChloeTaylor141) May 7, 2021
UK to offer under-40s alternative to AstraZeneca Covid-19 vaccine given rare blood clot concerns https://t.co/x8C0xsW4E1
— CNBC (@CNBC) May 7, 2021